NF-κB Inhibition Protects against Tumor-Induced Cardiac Atrophy in Vivo
Open Access
- 1 March 2011
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 178 (3) , 1059-1068
- https://doi.org/10.1016/j.ajpath.2010.12.009
Abstract
No abstract availableFunding Information
- Howard Hughes Medical Institute Research Training Fellowship
- University of North Carolina Program in Translational Science
- American Heart Association Scientist Development
- National Heart, Lung, and Blood Institute (R01HL104129)
This publication has 66 references indexed in Scilit:
- JunB transcription factor maintains skeletal muscle mass and promotes hypertrophyThe Journal of cell biology, 2010
- Muscle ring finger 1 mediates cardiac atrophy in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic miceBritish Journal of Cancer, 2009
- Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCPProceedings of the National Academy of Sciences, 2009
- Build it up-Tear it down: protein quality control in the cardiac sarcomereCardiovascular Research, 2008
- The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 geneAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- The IκB kinases IKKα and IKKβ are necessary and sufficient for skeletal muscle atrophyThe FASEB Journal, 2008
- IκB Kinase β Phosphorylates the K63 Deubiquitinase A20 To Cause Feedback Inhibition of the NF-κB PathwayMolecular and Cellular Biology, 2007
- Muscle cachexia is regulated by a p53–PW1/Peg3-dependent pathwayGenes & Development, 2006
- Cachexia in cancer patientsNature Reviews Cancer, 2002